Stryker Corporation SYK
Set alert
291.86 USD -19.89 -6.38%
At close · Oct 30
293.00 +1.14 +0.39%
After hours · Oct 30, 7:53 PM ET
282.18 Day range 299.17
269.75 52-week range 387.46
- YTD
- -16.96%
- 1 year
- -20.90%
- Open
- 287.97
- Prev close
- 311.75
- Mkt cap
- 111.95B
- Vol
- 6.44M
- Avg vol
- 2.66M
- EPS
- 9.65
- P/E
- 30.24
- Div yield
- 1.13%
More statistics
- Low
- 282.18
- High
- 299.17
- Forward P/E
- 17.51
- Beta
- 0.78
- Short ratio
- 2.15
- Inst. own
- 83.40%
- Dividend
- 3.52
- Ex-div date
- Sep 29, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 293.42
- 200-d avg
- 324.16
- 1y target
- 362.62
MAX chart
Events in this range
- Oct 30, 2026Rating: Needham · Buy → Buy
- Oct 30, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Oct 30, 2026Rating: Citizens · Market Outperform → Market Outperform
- Oct 30, 2026Downgrade: Canaccord Genuity · Buy → Hold
- Oct 30, 2026Rating: Barclays · Overweight → Overweight
- Oct 30, 2026Rating: RBC Capital · Outperform → Outperform
Signals (50)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 1, 2026 | 8 months ago |
| RSI: Overbought | Dec 1, 2025 | 11 months ago |
| RSI: Overbought | Dec 1, 2023 | 2 years ago |
| MACD: Buy Signal | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Jun 1, 2022 | 4 years ago |
| MACD: Sell Signal | Jun 1, 2022 | 4 years ago |
| RSI: Overbought | Dec 1, 2021 | 4 years ago |
| RSI: Overbought | Mar 1, 2020 | 6 years ago |
| RSI: Overbought | Sep 1, 2014 | 12 years ago |
| RSI: Overbought | Mar 1, 2014 | 12 years ago |
| MACD: Buy Signal | Dec 1, 2012 | 13 years ago |
| SMA: Bullish | Jun 1, 2012 | 14 years ago |
| SMA: Bullish | Jun 1, 2012 | 14 years ago |
| SMA: Bearish | Mar 1, 2012 | 14 years ago |
| SMA: Bearish | Mar 1, 2012 | 14 years ago |
| SMA: Bullish | Dec 1, 2011 | 14 years ago |
| SMA: Bullish | Dec 1, 2011 | 14 years ago |
| SMA: Bearish | Jun 1, 2011 | 15 years ago |
| SMA: Bearish | Jun 1, 2011 | 15 years ago |
| SMA: Bullish | Dec 1, 2010 | 15 years ago |
| SMA: Bullish | Sep 1, 2010 | 16 years ago |
| SMA: Bearish | Jun 1, 2010 | 16 years ago |
| SMA: Bearish | Jun 1, 2010 | 16 years ago |
| SMA: Bullish | Dec 1, 2009 | 16 years ago |
| SMA: Bullish | Sep 1, 2009 | 17 years ago |
| SMA: Bearish | Sep 1, 2008 | 18 years ago |
| SMA: Bearish | Sep 1, 2008 | 18 years ago |
| MACD: Sell Signal | Sep 1, 2008 | 18 years ago |
| MACD: Buy Signal | Dec 1, 2006 | 19 years ago |
| RSI: Overbought | Dec 1, 2006 | 19 years ago |
| SMA: Bullish | Jun 1, 2006 | 20 years ago |
| MACD: Sell Signal | Dec 1, 2005 | 20 years ago |
| SMA: Bearish | Sep 1, 2005 | 21 years ago |
| RSI: Overbought | Dec 1, 1998 | 27 years ago |
| SMA: Bullish | Sep 1, 1998 | 28 years ago |
| SMA: Bearish | Jun 1, 1998 | 28 years ago |
| RSI: Overbought | Sep 1, 1996 | 30 years ago |
| RSI: Overbought | Sep 1, 1995 | 31 years ago |
| MACD: Buy Signal | Dec 1, 1994 | 31 years ago |
| SMA: Bullish | Jun 1, 1994 | 32 years ago |
| SMA: Bearish | Mar 1, 1994 | 32 years ago |
| SMA: Bullish | Dec 1, 1993 | 32 years ago |
| MACD: Sell Signal | Jun 1, 1993 | 33 years ago |
| SMA: Bearish | Dec 1, 1992 | 33 years ago |
| RSI: Overbought | Mar 1, 1990 | 36 years ago |
| RSI: Overbought | Sep 1, 1989 | 37 years ago |
| SMA: Bullish | Dec 1, 1987 | 38 years ago |
| SMA: Bearish | Sep 1, 1987 | 39 years ago |
Key statistics
- Market cap
- 111.84B
- Enterprise value
- 131.55B
- Trailing P/E
- 30.22
- Forward P/E
- 17.51
- PEG ratio
- 1.46
- Price / sales
- 4.33
- Price / book
- 4.66
- EPS (TTM)
- 9.65
- Beta
- 0.78
- Dividend yield
- 1.13%
- Payout ratio
- 36.06%
- Profit margin
- 14.43%
- Revenue (TTM)
- 25.84B
- Revenue growth
- 9.40%
- Free cash flow
- 4.11B
- Total cash
- 3.48B
- Total debt
- 15.45B
- Return on equity
- 16.51%
- Shares outstanding
- 383.57M
- Short % of float
- 1.55%
- 50-day average
- 293.42
- 200-day average
- 324.16
Analyst view
Consensus: buy
Buy
Price target (mean) 362.62 +24.2% upside
Now 291.86
- Target (low)
- 298.00
- Target (mean)
- 362.62
- Target (high)
- 465.00
Ratings (0m) 30 23 buy · 7 hold · 0 sell
- Strong buy8
- Buy15
- Hold7
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 5.09.
Financials — quick view
SYK Revenue — quarterly 6.52B
SYK Net income — quarterly 753.00M
SYK EPS — quarterly 1.97
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 5.04 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 3.55 | 3.52 | -0.03 | -0.85% |
| Jul 30, 2026 | Jun 30, 2026 | 3.49 | 3.69 | +0.20 | +5.73% |
| Apr 30, 2026 | Mar 31, 2026 | 2.98 | 2.60 | -0.38 | -12.75% |
| Jan 29, 2026 | Dec 31, 2025 | 4.40 | 4.47 | +0.07 | +1.59% |
| Oct 30, 2025 | Sep 30, 2025 | 3.13 | 3.19 | +0.06 | +1.92% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | RBC Capital | main | Outperform | Outperform |
| Oct 30, 2026 | Barclays | main | Overweight | Overweight |
| Oct 30, 2026 | Canaccord Genuity | down | Buy | Hold |
| Oct 30, 2026 | Citizens | main | Market Outperform | Market Outperform |
| Oct 30, 2026 | Evercore ISI Group | main | Outperform | Outperform |
| Oct 30, 2026 | Needham | main | Buy | Buy |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- stryker.com
News
- JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $340
- Citigroup Maintains Buy on Stryker, Lowers Price Target to $315
- TD Cowen Maintains Hold on Stryker, Lowers Price Target to $290
- SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
- Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
- RBC Capital Maintains Outperform on Stryker, Lowers Price Target to $375
- Barclays Maintains Overweight on Stryker, Lowers Price Target to $365
- SYK Q3 Earnings Call Highlights Softer Demand and Revised Outlook
- Canaccord Genuity Downgrades Stryker to Hold, Lowers Price Target to $300
- Citizens Maintains Market Outperform on Stryker, Lowers Price Target to $390
Your note
Sign in to keep a note on SYK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECKER YIN C | Officer | Conversion of Exercise of derivative security | Mar 20, 2025 | 36,052 |
| CROTTY DYLAN BRAM | Officer | Sale | Aug 20, 2026 | 0 |
| FINK MARY KATHRYN | Officer | Sale | May 10, 2026 | 0 |
| GOLSTON ALLAN C | Director | Sale | Feb 17, 2025 | 14,895 |
| LOBO KEVIN A | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 19, 2026 | 222,952 |
| MENON VIJU S | Officer | Conversion of Exercise of derivative security | Mar 19, 2026 | 17,580 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.15% | 27,414,742 | 7.99B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 5.88% | 22,536,843 | 6.57B | Jun 29, 2026 |
| JPMORGAN CHASE & CO | 4.50% | 17,260,943 | 5.03B | Jun 29, 2026 |
| State Street Corporation | 4.05% | 15,532,565 | 4.53B | Jun 29, 2026 |
| Greenleaf Trust | 3.95% | 15,155,933 | 4.42B | Sep 29, 2026 |
| Price (T.Rowe) Associates Inc | 3.11% | 11,916,057 | 3.47B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.86% | 10,952,979 | 3.19B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.33% | 8,941,926 | 2.61B | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.21% | 4,650,741 | 1.36B | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.17% | 4,478,734 | 1.31B | Aug 30, 2026 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.13% | 4,318,841 | 1.26B | Sep 29, 2026 |
| SELECT SECTOR SPDR TRT-State Street Health Care Select Sector SPDR ETF | 0.64% | 2,469,410 | 720.04M | Sep 29, 2026 |